Literature DB >> 18687228

Can metformin undo weight gain induced by antipsychotics?

Sarah-Anne Schumann1, Bernard Ewigman.   

Abstract

Entities:  

Year:  2008        PMID： 18687228      PMCID： PMC3183916     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  10 in total

Review 1.  Consensus development conference on antipsychotic drugs and obesity and diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

Review 2.  Interventions to reduce weight gain in schizophrenia.

Authors:  G Faulkner; T Cohn; G Remington
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  Have pedometer, will travel.

Authors:  Kathleen Rowland; Sarah-Anne Schumann
Journal:  J Fam Pract       Date:  2008-02       Impact factor: 0.493

4.  Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.

Authors:  Mario Alvarez-Jiménez; Cesar González-Blanch; Jose Luis Vázquez-Barquero; Rocío Pérez-Iglesias; Obdulia Martínez-García; Teresa Pérez-Pardal; Mari Luz Ramírez-Bonilla; Benedicto Crespo-Facorro
Journal:  J Clin Psychiatry       Date:  2006-08       Impact factor: 4.384

5.  A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.

Authors:  David J Klein; Elizabeth M Cottingham; Michael Sorter; Bruce A Barton; John A Morrison
Journal:  Am J Psychiatry       Date:  2006-12       Impact factor: 18.112

6.  Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.

Authors:  Trino Baptista; Jessan Martínez; Anny Lacruz; Nairy Rangel; Serge Beaulieu; Ana Serrano; Yinet Arapé; Maritza Martinez; Soaira de Mendoza; Luis Teneud; Luis Hernández
Journal:  Can J Psychiatry       Date:  2006-03       Impact factor: 4.356

7.  Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial.

Authors:  Trino Baptista; Nairy Rangel; Virginia Fernández; Edgardo Carrizo; Yamily El Fakih; Euderruh Uzcátegui; Tatiana Galeazzi; María A Gutiérrez; Mercedes Servigna; Adriana Dávila; Marycelvia Uzcátegui; Ana Serrano; Lisette Connell; Serge Beaulieu; Enma Araujo de Baptista
Journal:  Schizophr Res       Date:  2007-05-08       Impact factor: 4.939

Review 8.  Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.

Authors:  John W Newcomer
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

Review 9.  Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.

Authors:  Peter J Weiden
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

10.  Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.

Authors:  Ren-Rong Wu; Jing-Ping Zhao; Hua Jin; Ping Shao; Mao-Sheng Fang; Xiao-Feng Guo; Yi-Qun He; Yi-Jun Liu; Jin-Dong Chen; Le-Hua Li
Journal:  JAMA       Date:  2008-01-09       Impact factor: 56.272
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.